Stock listing
Abvc Biopharma, Inc.
Selected listing: ABVC · NASDAQ · USD · US
Abvc Biopharma, Inc. (NASDAQ:ABVC), Health Technology. Latest release Jun 23, 2026: ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc.…
- Ticker
- NASDAQ:ABVC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Abvc Biopharma, Inc.
Abvc Biopharma, Inc. is a publicly traded company listed under the ticker ABVC on the American market. Abvc Biopharma focuses on developing innovative biopharmaceuticals aimed at addressing unmet medical needs.
Latest news from Abvc Biopharma, Inc.
ABVC BioPharma, Inc. Announces Planned Spin-Off of BioKey (Cayman), Inc. Through Dividend Distribution of BioKey Shares to ABVC Shareholders
June 23, 2026
ABVC BioPharma Provides Corporate and Structural Update
February 24, 2026
ABVC BioPharma Highlights Safety Profile of Its Plant-Based ADHD Candidate Amid Growing Concerns About Psychiatric Polypharmacy in the United States
December 2, 2025
ABVC BioPharma Highlights Strengthened Operations at BioKey's 28,176-sq.-ft. Silicon Valley Facility, Featuring U.S.-Based Multi-Product Capabilities Including Functional Foods, and Expansion Outlook Supporting Up to [1,000] Jobs by 2030
November 26, 2025
ABVC Receives US$250,000 From ForSeeCon; Vitargus(R) Total Licensing Fee up to US$33.5 Million; US$816,000 Already Received
November 21, 2025
Research Abvc Biopharma, Inc.
Abvc Biopharma, Inc. company profile
View the public company page for Abvc Biopharma, Inc. on 6ix.
Abvc Biopharma, Inc. news
Read company news and market updates connected to Abvc Biopharma, Inc..
Abvc Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Abvc Biopharma, Inc..